HbA1c 분석기 시장 : 제품 유형별, 최종 사용자별, 지역별 - 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

HbA1c Analyzers Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,823,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,604,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 세계의 HbA1c 분석기 시장에 대한 상세한 분석을 발표하고 주요 시장 동향, 성장 촉진요인, 과제, 신흥 동향 등을 종합적으로 정리했습니다. 이 보고서는 HbA1c 분석기 시장에 대한 귀중한 인사이트를 제공하고 2024년부터 2033년까지 시장의 성장 궤도를 예측하는 독점 데이터와 통계를 제시합니다.

세계의 HbA1c 분석기 시장은 2024년부터 2033년까지의 CAGR이 7.2%로 예측되어 큰 성장이 전망되고 있습니다. 2024년 시장 규모는 2,160억 5,000만 달러로 추정되며, 2033년에는 3,468억 달러에 이를 것으로 예상됩니다.

주요 인사이트

• HbA1c 분석 장치 시장의 CAGR(2024-2033년) : 7.2%
• HbA1c 분석기 시장 규모(2024년) : 2,160억 5,000만 달러
• HbA1c 분석기 시장 규모(2033년) : 3,468억 달러

조사 범위 :

이 보고서는 세계의 HbA1c 분석기 시장 성장을 가속하는 요인을 조사하고 시장 역학, 기술적 진보, 규제 프레임 워크 등을 다룹니다. 시장 내 성장 촉진요인, 과제 및 기회를 평가하고, 경쟁 정보나 주요 시장 기업의 전략적 이니셔티브도 아울러 제공합니다.

시장 성장 촉진요인 :

HbA1c 분석기 시장의 성장은 주로 세계 당뇨병 유병률 증가에 의해 초래됩니다. 또한 당뇨병 환자에서 혈당 조절의 중요성에 대한 의식이 높아짐에 따라 HbA1c 검사에 대한 수요가 증가하고 있습니다. 또한 혁신적이고 사용자 친화적인 분석기 개발로 이어지는 기술의 발전도 시장 성장에 크게 기여합니다.

시장 성장 억제요인 :

HbA1c 분석기 시장의 과제에는 분석기 승인 및 표준화에 관한 규제 제약이 포함됩니다. 게다가 HbA1c 측정의 정확성과 정확성에 관한 문제는 시장 확대의 큰 장애물이 되고 있습니다. 게다가 첨단 분석기에는 비용이 많이 들기 때문에 신흥국에서의 보급에는 한계가 있습니다.

시장 기회 :

HbA1c 분석기 시장의 비즈니스 기회는 포인트 오브 케어 검사에 적합한 휴대용, 비용 효율적인 분석기 개척에 있습니다. 또한 인공지능과 머신러닝 알고리즘을 분석 장치에 통합하면 진단 정확도와 효율성이 향상됩니다. 또한, 당뇨병 관리 프로그램을 실시하기 위한 의료기관과 진단기업의 협업은 유리한 성장 전망을 보여줍니다.

이 보고서에서 다루는 주요 질문

• 당뇨병 관리에서 HbA1c 분석기의 채택을 촉진하는 주요 요인은 무엇인가?
• 기술 혁신은 HbA1c 검사의 상황을 어떻게 바꾸고 있는가?
• 세계의 HbA1c 분석기 시장에서 예상되는 주요 시장 동향 및 장래 전망은?
• HbA1c 분석기 시장의 주요 기업은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위 및 분류
• 시장의 정의, 범위 및 제한

제3장 주요 시장 동향

제4장 중요 성공 요인

제5장 세계의 HbA1c 분석기 시장 : 가격 분석

• 제품 유형별 국가별 가격 분석
• 세계 평균 가격 분석 벤치마크

제6장 세계의 HbA1c 분석기 시장 : 수요 분석

• 과거 시장가치분석(2019-2023년)
• 현재 및 장래 시장 가치 예측(2024-2033년)
  • 전년대비 성장 동향 분석
  • 절대액의 기회 분석

제7장 시장 배경

• 거시경제 요인
• 예측 요인 : 관련성 및 영향
• 밸류체인
• 지역별 설치 기반 분석
• 시장 역학

제8장 세계의 HbA1c 분석기 시장 분석 : 제품 유형별

• 서문 : 주요 조사 결과
• 과거 시장 규모 및 수량 분석 : 제품 유형별(2019-2023년)
• 현재 및 장래 시장 규모와 수량 분석 및 예측 : 제품 유형별(2024-2033년)
  • 기기
  • 시약 및 소모품
• 제품 유형별 매력도 분석

제9장 세계의 HbA1c 분석기 시장 분석 : 기술별

• 서문 : 주요 조사 결과
• 과거 시장 규모 분석 : 기술별(2019-2023년)
• 현재 및 장래 시장 규모 분석 및 예측 : 기술별(2024-2033년)
  • 이온 교환 크로마토그래피
  • 보로네이트 친화성 고속 액체 크로마토그래피
  • 고속 액체 크로마토그래피
  • 보로네이트 친화성 기술
• 기술별 시장 매력도 분석

제10장 세계의 HbA1c 분석기 시장 분석 : 모달리티별

• 서문 : 주요 조사 결과
• 과거 시장 규모 분석 : 모달리티별(2019-2023년)
• 현재 및 장래 시장 규모 분석 및 예측 : 모달리티별(2024-2033년)
  • 휴대용 HbA1c 분석기
  • 벤치탑 HbA1c 분석기
• 모달리티별 시장 매력 분석

제11장 세계의 HbA1c 분석기 시장 분석 : 최종 사용자별

• 서문 : 주요 조사 결과
• 과거 시장 규모 분석 : 최종 사용자별(2019-2023년)
• 현재 및 장래 시장 분석 및 예측 : 최종 사용자별(2024-2033년)
  • 병원
  • 진단센터
  • 학술연구기관
• 최종 사용자별 시장 매력도 분석

제12장 세계의 HbA1c 분석기 시장 분석 : 지역별

• 서문
• 과거 시장 규모 분석 : 지역별(2019-2023년)
• 현재 시장 규모 분석 및 예측 : 지역별(2024-2033년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 중동 및 아프리카
  • 동아시아
  • 남아시아
  • 오세아니아
• 지역별 시장 매력도 분석

제13장 북미의 HbA1c 분석기 시장 분석

제14장 라틴아메리카의 HbA1c 분석기 시장 분석

제15장 유럽의 HbA1c 분석기 시장 분석

제16장 남아시아의 HbA1c 분석기 시장 분석

제17장 동아시아의 HbA1c 분석기 시장 분석

제18장 오세아니아의 HbA1c 분석기 시장 분석

제19장 중동 및 아프리카의 HbA1c 분석기 시장 분석

제20장 시장 구조 분석

• 기업 Tier별 시장 구조 분석(HbA1c 분석 장치)

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁의 상세
  • Abbott
  • ApexBio
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Convergent Technologies GmbH &Co. KG
  • EKF Diagnostics
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • i-SENS, Inc.
  • labONE, Inc.
  • LITE-ON TECHNOLOGY CORPORATION
  • Meril Life Sciences Pvt. Ltd.
  • OSANG Healthcare
  • TaiDoc Technology Corporation
  • Tosoh Corporation
  • Trinity Biotech
  • Zivak Technologies USA

제22장 전제 및 약어

제23장 조사 방법

AJY

영문 목차

영문목차

Persistence Market Research has recently published an in-depth analysis of the global HbA1c Analyzers Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the HbA1c Analyzers Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2024 to 2033.

The global HbA1c Analyzers Market is poised for significant growth, with a projected CAGR of 7.2% from 2024 to 2033. In 2024, the market size was valued at US$ 216.05 billion, and it is anticipated to reach US$ 346.8 billion by 2033.

Key Insights:

• HbA1c Analyzers Market CAGR (2024 - 2033): 7.2%
• HbA1c Analyzers Market Size (2024): US$ 216.05 Billion
• HbA1c Analyzers Market Size (2033): US$ 346.8 Billion

Report Scope:

This report delves into the factors propelling the growth of the HbA1c Analyzers Market globally, encompassing market dynamics, technological advancements, and regulatory frameworks. It evaluates growth drivers, challenges, and opportunities within the market, alongside competitive intelligence and strategic initiatives undertaken by key market players.

Market Growth Drivers:

The growth of the HbA1c Analyzers Market is primarily driven by the rising prevalence of diabetes worldwide. Additionally, the increasing awareness regarding the importance of glycemic control among diabetic patients fuels the demand for HbA1c testing. Moreover, technological advancements leading to the development of innovative and user-friendly analyzers contribute significantly to market growth.

Market Restraints:

Challenges within the HbA1c Analyzers Market include regulatory constraints concerning the approval and standardization of analyzers. Moreover, issues related to the accuracy and precision of HbA1c measurements pose significant hurdles to market expansion. Additionally, the high cost associated with advanced analyzers limits their adoption in emerging economies.

Market Opportunities:

Opportunities within the HbA1c Analyzers Market lie in the development of portable and cost-effective analyzers suitable for point-of-care testing. Furthermore, the integration of artificial intelligence and machine learning algorithms into analyzers enhances diagnostic accuracy and efficiency. Moreover, collaborations between healthcare organizations and diagnostic companies for the implementation of diabetes management programs present lucrative growth prospects.

Key Questions Answered in the Report:

• What are the primary factors driving the adoption of HbA1c analyzers in diabetes management?
• How are technological innovations reshaping the landscape of HbA1c testing?
• What are the key market trends and future prospects anticipated in the global HbA1c Analyzers Market?
• Who are the leading players in the HbA1c Analyzers Market?

Competitive Intelligence and Business Strategy:

The competitive landscape of the HbA1c Analyzers Market features prominent players such as Abbott, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories, Inc., leveraging their extensive expertise and global reach. Other significant contributors include ARKRAY Inc., EKF Diagnostics, and Tosoh Corporation, each offering innovative solutions in HbA1c testing. Additionally, emerging players like ApexBio and Zivak Technologies USA are making strides in the market with their technological advancements. This diverse competitive environment fosters innovation and drives market growth through product differentiation and strategic collaborations among key industry players.

Key Companies Profiled:

• Abbott
• ApexBio
• ARKRAY, Inc.
• Bio-Rad Laboratories, Inc.
• Convergent Technologies GmbH & Co. KG
• EKF Diagnostics
• Erba Mannheim
• F. Hoffmann-La Roche Ltd
• HemoCue AB
• i-SENS, Inc.
• labONE, Inc.
• LITE-ON TECHNOLOGY CORPORATION
• Meril Life Sciences Pvt. Ltd.
• OSANG Healthcare
• TaiDoc Technology Corporation
• Tosoh Corporation
• Trinity Biotech
• Zivak Technologies USA

Market Segmentation:

HbA1c Analyzers Market by Technology

• High-performance Liquid Chromatography (HPLC)
• Ion Exchange Chromatography
• Boronate Affinity Technology
• Boronate Affinity HPLC

HbA1c Analyzers Market by End-user

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others

HbA1c Analyzers Market by Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Key Success Factors

5. Global HbA1c Analyzers Market - Pricing Analysis

• 5.1. Country Pricing Analysis By Product Type
• 5.2. Global Average Pricing Analysis Benchmark

6. Global HbA1c Analyzers Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 6.2.1. Y-o-Y Growth Trend Analysis
  • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

• 7.1. Macro-Economic Factors
  • 7.1.1. Global GDP Growth Outlook
  • 7.1.2. Healthcare Expenditure by Country
• 7.2. Forecast Factors - Relevance & Impact
  • 7.2.1. New/Improved Product Launches
  • 7.2.2. Technological Advancements
  • 7.2.3. Prevalence of Diabetes
  • 7.2.4. Reimbursement Policies
  • 7.2.5. Product Penetration Rate across End Users
  • 7.2.6. Diagnosis Seeking Rate
  • 7.2.7. Adoption Seeking Rate
• 7.3. Value Chain
• 7.4. Install Base Analysis by Region
• 7.5. Market Dynamics
  • 7.5.1. Drivers
  • 7.5.2. Restraints
  • 7.5.3. Opportunity Analysis

8. Global HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2033
  • 8.3.1. Equipments
    • 8.3.1.1. Semi-Automated HbA1c Analyzers
    • 8.3.1.2. Automated HbA1c Analyzers
  • 8.3.2. Reagents and Consumables
    • 8.3.2.1. Calibrator Kit
    • 8.3.2.2. Control Kit
    • 8.3.2.3. Reagent Kit Market
• 8.4. Attractiveness Analysis By Product Type

9. Global HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033, by Technology

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2024-2033
  • 9.3.1. Ion Exchange Chromatography
  • 9.3.2. Boronate Affinity High-Performance Liquid Chromatography
  • 9.3.3. High-Performance Liquid Chromatography
  • 9.3.4. Boronate Affinity Technology
• 9.4. Market Attractiveness Analysis By Technology

10. Global HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033, by Modality

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By Modality, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Modality, 2024-2033
  • 10.3.1. Portable HbA1c Analyzers
  • 10.3.2. Benchtop HbA1c Analyzers
• 10.4. Market Attractiveness Analysis By Modality

11. Global HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033, by End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
  • 11.3.1. Hospitals
  • 11.3.2. Diagnostics Centers
  • 11.3.3. Academic and Research Institute
• 11.4. Market Attractiveness Analysis By End User

12. Global HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. Middle East and Africa (MEA)
  • 12.3.5. East Asia
  • 12.3.6. South Asia
  • 12.3.7. Oceania
• 12.4. Market Attractiveness Analysis By Region

13. North America HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product Type
  • 13.3.3. By Technology
  • 13.3.4. By Modality
  • 13.3.5. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product Type
  • 13.4.3. By Technology
  • 13.4.4. By Modality
  • 13.4.5. By End User
• 13.5. Drivers and Restraints - Impact Analysis

14. Latin America HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Brazil
    • 14.3.1.2. Mexico
    • 14.3.1.3. Rest of Latin America
  • 14.3.2. By Product Type
  • 14.3.3. By Technology
  • 14.3.4. By Modality
  • 14.3.5. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product Type
  • 14.4.3. By Technology
  • 14.4.4. By Modality
  • 14.4.5. By End User
• 14.5. Drivers and Restraints - Impact Analysis

15. Europe HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Product Type
  • 15.3.3. By Technology
  • 15.3.4. By Modality
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product Type
  • 15.4.3. By Technology
  • 15.4.4. By Modality
  • 15.4.5. By End User
• 15.5. Drivers and Restraints - Impact Analysis

16. South Asia HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Thailand
    • 16.3.1.3. Indonesia
    • 16.3.1.4. Malaysia
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product Type
  • 16.3.3. By Technology
  • 16.3.4. By Modality
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product Type
  • 16.4.3. By Technology
  • 16.4.4. By Modality
  • 16.4.5. By End User
• 16.5. Drivers and Restraints - Impact Analysis

17. East Asia HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. China
    • 17.3.1.2. Japan
    • 17.3.1.3. South Korea
  • 17.3.2. By Product Type
  • 17.3.3. By Technology
  • 17.3.4. By Modality
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product Type
  • 17.4.3. By Technology
  • 17.4.4. By Modality
  • 17.4.5. By End User
• 17.5. Drivers and Restraints - Impact Analysis

18. Oceania HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Product Type
  • 18.3.3. By Technology
  • 18.3.4. By Modality
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product Type
  • 18.4.3. By Technology
  • 18.4.4. By Modality
  • 18.4.5. By End User
• 18.5. Drivers and Restraints - Impact Analysis

19. Middle East and Africa HbA1c Analyzers Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Northern Africa
    • 19.3.1.3. South Africa
    • 19.3.1.4. Rest of Middle East and Africa
  • 19.3.2. By Product Type
  • 19.3.3. By Technology
  • 19.3.4. By Modality
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product Type
  • 19.4.3. By Technology
  • 19.4.4. By Modality
  • 19.4.5. By End User
• 19.5. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

• 20.1. Market Structure Analysis by Tier of Companies (HbA1c Analyzers)

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Abbott
    • 21.3.1.1. Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.1.4. Strategy Overview
  • 21.3.2. ApexBio
    • 21.3.2.1. Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.2.4. Strategy Overview
  • 21.3.3. ARKRAY, Inc.
    • 21.3.3.1. Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.3.4. Strategy Overview
  • 21.3.4. Bio-Rad Laboratories, Inc.
    • 21.3.4.1. Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.4.4. Strategy Overview
  • 21.3.5. Convergent Technologies GmbH & Co. KG
    • 21.3.5.1. Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.5.4. Strategy Overview
  • 21.3.6. EKF Diagnostics
    • 21.3.6.1. Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.6.4. Strategy Overview
  • 21.3.7. Erba Mannheim
    • 21.3.7.1. Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.7.4. Strategy Overview
  • 21.3.8. F. Hoffmann-La Roche Ltd
    • 21.3.8.1. Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.8.4. Strategy Overview
  • 21.3.9. HemoCue AB
    • 21.3.9.1. Overview
    • 21.3.9.2. Product Portfolio
    • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.9.4. Strategy Overview
  • 21.3.10. i-SENS, Inc.
    • 21.3.10.1. Overview
    • 21.3.10.2. Product Portfolio
    • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.10.4. Strategy Overview
  • 21.3.11. labONE, Inc.
    • 21.3.11.1. Overview
    • 21.3.11.2. Product Portfolio
    • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.11.4. Strategy Overview
  • 21.3.12. LITE-ON TECHNOLOGY CORPORATION
    • 21.3.12.1. Overview
    • 21.3.12.2. Product Portfolio
    • 21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.12.4. Strategy Overview
  • 21.3.13. Meril Life Sciences Pvt. Ltd.
    • 21.3.13.1. Overview
    • 21.3.13.2. Product Portfolio
    • 21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.13.4. Strategy Overview
  • 21.3.14. OSANG Healthcare
    • 21.3.14.1. Overview
    • 21.3.14.2. Product Portfolio
    • 21.3.14.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.14.4. Strategy Overview
  • 21.3.15. TaiDoc Technology Corporation
    • 21.3.15.1. Overview
    • 21.3.15.2. Product Portfolio
    • 21.3.15.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.15.4. Strategy Overview
  • 21.3.16. Tosoh Corporation
    • 21.3.16.1. Overview
    • 21.3.16.2. Product Portfolio
    • 21.3.16.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.16.4. Strategy Overview
  • 21.3.17. Trinity Biotech
    • 21.3.17.1. Overview
    • 21.3.17.2. Product Portfolio
    • 21.3.17.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.17.4. Strategy Overview
  • 21.3.18. Zivak Technologies USA
    • 21.3.18.1. Overview
    • 21.3.18.2. Product Portfolio
    • 21.3.18.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.18.4. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료